Sunil Badve's Publications

About Sunil Badve's Publications

Program Lead, Cardiometabolic Trials, Renal and Metabolic Program

  • Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes

    JAMA Date published:

  • Long-term outcomes of end-stage kidney disease for patients with lupus nephritis

    Kidney International Date published:

  • The β-Blocker to Lower Cardiovascular Dialysis Events (BLOCADE) Feasibility Study: A Randomized Controlled Trial

    American Journal of Kidney Diseases Date published:

  • MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS

    Nephrology Dialysis Transplantation Date published:

  • Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study

    Nephrology Date published:

  • APPETITE PREDICTS INTAKE AND NUTRITIONAL STATUS IN PATIENTS RECEIVING PERITONEAL DIALYSIS

    Journal of Renal Care Date published:

  • Baseline characteristics of the omega-3 fatty acids ( F ish oils) and A spirin in V ascular access OU tcomes in RE nal D isease ( FAVOURED ) study

    Nephrology Date published:

  • The effect of pentoxifylline on oxidative stress in chronic kidney disease patients with erythropoiesis-stimulating agent hyporesponsiveness: Sub-study of the HERO trial

    Redox Report Date published:

  • EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS

    Date published:

  • EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES: A SYSTEMATIC REVIEWAND META-ANALYSIS

    Date published:

  • EFFECT OF THE BETA-BLOCKER CARVEDILOL ON BIOMARKERS OF CARDIOVASCULAR DISEASE IN PATIENTS RECEIVING DIALYSIS

    Date published:

  • CARDIOVASCULAR BIOMARKERS, GLOBAL LEFT VENTRICULAR STRAIN, AND TOLERABILITY OF THE BETA-BLOCKER CARVEDILOL IN PATIENTS RECEIVING DIALYSIS

    Date published:

  • The Effect of Exit-Site Antibacterial Honey versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published:

  • Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Glomerular filtration rate decline as a surrogate end point in kidney disease progression trials

    Nephrology Dialysis Transplantation Date published:

  • Socio-Economic Status and Peritonitis in Australian Non-Indigenous Peritoneal Dialysis Patients

    Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis Date published: